| Stage | SOLS | % of rev | HUN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.1B | 100.00% | $1.7B | 100.00% | HUN ×1.45 |
| Gross profit | $370M | 32.23% | $245M | 14.73% | SOLS +17.5pp |
| Operating income | $197M | 17.16% | $37M | 2.22% | SOLS +14.9pp |
| Pre-tax income | $176M | 15.33% | $26M | 1.56% | SOLS +13.8pp |
| Net income | $134M | 11.67% | $7M | 0.42% | SOLS +11.3pp |
| Stage | SOLS | HUN | Gap · A − B |
|---|---|---|---|
| Revenue | $1.1B100.00% | $1.7B100.00% | HUN ×1.45 |
| Gross profit | 32.23%$370M | 14.73%$245M | SOLS +17.5pp |
| Operating income | 17.16%$197M | 2.22%$37M | SOLS +14.9pp |
| Pre-tax income | 15.33%$176M | 1.56%$26M | SOLS +13.8pp |
| Net income |
| 11.67%$134M |
| 0.42%$7M |
| SOLS +11.3pp |
No shared counterparties.